Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients
Methods| Transplant recipients without prior polymerase chain reaction–confirmed COVID-
19 were recruited from across the US to participate in this prospective cohort through a
digital campaign. Those who completed the 2-dose SARS-CoV-2 mRNA vaccine series
between December 16, 2020, and March 13, 2021, were included and followed up through
April 13, 2021. As described previously, 3 semiquantitative antispike serologic testing was
undertaken with the Roche Elecsys anti–SARS-CoV-2 S enzyme immunoassay, positive …
19 were recruited from across the US to participate in this prospective cohort through a
digital campaign. Those who completed the 2-dose SARS-CoV-2 mRNA vaccine series
between December 16, 2020, and March 13, 2021, were included and followed up through
April 13, 2021. As described previously, 3 semiquantitative antispike serologic testing was
undertaken with the Roche Elecsys anti–SARS-CoV-2 S enzyme immunoassay, positive …